TNF and inflammatory bowel disease: To date, few studies have looked at the relationship between biological therapy and vitamin D pathways [15,16,17,18], but in a retrospective study of patients with inflammatory bowel disease (IBD) treated with biologics, vitamin D insufficiency was correlated with the earlier cessation of anti-TNF-α drugs due to the failure of the therapy, especially in patients not exposed to pharmaceutical supplementation [19].